Inventor · disambiguated record
Heather Brodkin
Also filed as: BRODKIN HEATHER · BRODKIN HEATHER R
15 granted patents·17 pending applications·46 citations·filing 2015–2025
90Inventor score
Top patents by PatentIndex Score
32 records- 0196US11352403B2Activatable interleukin-2 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Granted Jun 7, 2022·6 cites·13 claims
- 0296US10696724B2Activatable interleukin-2 polypeptidesWEREWOLF THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·18 cites·11 claims
- 0395US10696723B2Activatable interleukin 12 polypeptidesWEREWOLF THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·15 cites·12 claims
- 0494US11535658B2Activatable interleukin-2 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2021·Granted Dec 27, 2022·2 cites·21 claims
- 0593US11981716B2Activatable interleukin-2 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2021·Granted May 14, 2024·2 cites·13 claims
- 0683US10227413B2Anti-neuropilin antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·2 cites·20 claims
- 0782US2024358796A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0881US11186644B2Anti-neuropilin antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2019·Granted Nov 30, 2021·1 cites·11 claims
- 0979US12076371B2Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2023·Granted Sep 3, 2024·0 cites·29 claims
- 1078US12275769B2Activatable interleukin 12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Granted Apr 15, 2025·0 cites·14 claims
- 1178US12036266B2Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Granted Jul 16, 2024·0 cites·19 claims
- 1278US2024262880A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1375US11739132B2Separation moieties and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·0 cites·16 claims
- 1475US2024174725A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1574US2025179138A1Activatable interleukin 12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1674US2023272028A1Separation moieties and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1774US2023051423A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1870US11453710B2Activatable interleukin 12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·0 cites·16 claims
- 1968US2022098312A1Anti-neuropilin antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2065US2024216470A1Inducible il-2 and pd-1/pd-l1 combination therapyWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2165US2024216505A1Inducible cytokine prodrug and pd-1/pd-l1 combination therapyWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2265US2024216474A1Activatable interferon polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2364US10881741B2Single chain Fc fusion proteinsALKERMES INC·Filed 2018·Granted Jan 5, 2021·0 cites·15 claims
- 2464US2021177983A1SINGLE CHAIN Fc FUSION PROTEINSALKERMES INC·Filed 2020·Application pending·0 cites
- 2564US2021130430A1Activatable cytokine polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2662US2021115102A1Separation moieties and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2760US2024043488A1Activatable il-12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2859US2024374687A1Il-2 prodrugWEREWOLF THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2958US2021269542A1Anti-gitr antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3052US10988545B2Anti-GITR antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Apr 27, 2021·0 cites·11 claims
- 3146US2016175458A1Single chain fc fusion proteinsALKERMES INC·Filed 2015·Application pending·0 cites
- 3240US11453720B2Anti-TIGIT antigen-binding proteins and methods of use thereofPOTENZA THERAPEUTICS INC·Filed 2018·Granted Sep 27, 2022·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Heather Brodkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →